Apheresis against Long-COVID?
According to the congress report of the 14th annual meeting of the German Society of Nephrology, ten patients with severe ME/CFS underwent immunapheresis. In 7 out of 10 patients this leads to a significant improvement in symptoms. Prof. Dr. Scheibenbogen suspects an apheresis effect on the beta cell compartment, because autoantibodies against ß1 and ß2…